![](/img/cover-not-exists.png)
120P Survival outcomes of metastatic breast cancer who have been treated with bevacizumab and eribulin in the real world. - BEV + PTX followed by eribulin versus the reverse sequence
Matsui, K., Earashi, M., Nagata, T., Yoshikawa, A., Fukushima, W., Nozaki, Z., Tanada, Y., Oyama, K., Shimada, K., Kiyohara, K., Shimizu, T., Iwata, K., Yoshida, T., Ii, T., Maeda, K.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw577.004
Date:
December, 2016
File:
PDF, 41 KB
english, 2016